Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > black out is over, but where's the beef?

<< Previous

Bullboard Posts

Next >>

Comment by inthnoon Jan 04, 2024 10:53am

106 Views

Post# 35810445

RE:RE:RE:RE:RE:black out is over, but where's the beef?

Also I am guessing that you all still think that CF is a God for getting you all pumped up and now we know there is no nda and no partnership or BO at this time and now yipee ONC is going it alone so they say for the panc trial. Tell me how that is a good thing especially since they will now have to raise a ton of money and dilute shareholders once again. Was this really a good PR with lots to look forward to or just a rehash and anticipation of things to hopefully come.

<< Previous

Bullboard Posts

Next >>

Junior helium miner will explore record discovery in Q4